Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
JACC. Cardiovascular Interventions
|
March 24, 2017
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry
Michela Faggioni, Usman Baber, Samantha Sartori, et al.
The American Journal of Cardiology
|
August 6, 2017
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)
Mikkel Schoos, Jaya Chandrasekhar, Usman Baber, et al.
Lancet (London, England)
|
September 6, 2013
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
Roxana Mehran, Usman Baber, Philippe Gabriel Steg, et al.
Circulation. Cardiovascular Interventions
|
March 29, 2020
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry
Sabato Sorrentino, Samantha Sartori, Usman Baber, et al.
Circulation. Cardiovascular Interventions
|
June 6, 2018
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)
Usman Baber, Shawn X Li, Rebecca Pinnelas, et al.
Circulation. Cardiovascular Interventions
|
April 19, 2019
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention
Michela Faggioni, Usman Baber, Samantha Sartori, et al.
The American Journal of Cardiology
|
October 2, 2018
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry)
Sabato Sorrentino, Gennaro Giustino, Usman Baber, et al.
Thrombosis and Haemostasis
|
August 1, 2019
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry
Birgit Vogel, Jaya Chandrasekhar, Usman Baber, et al.
Clinical Cardiology
|
May 21, 2015
Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design
Heerajnarain Bulluck, Georg M Fröhlich, Shah Mohdnazri, et al.
JACC. Cardiovascular Interventions
|
May 25, 2019
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry
Lauren C Joyce, Usman Baber, Bimmer E Claessen, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
JACC. Cardiovascular Interventions
|
March 24, 2017
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry
Michela Faggioni, Usman Baber, Samantha Sartori, et al.
The American Journal of Cardiology
|
August 6, 2017
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry)
Mikkel Schoos, Jaya Chandrasekhar, Usman Baber, et al.
Lancet (London, England)
|
September 6, 2013
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
Roxana Mehran, Usman Baber, Philippe Gabriel Steg, et al.
Circulation. Cardiovascular Interventions
|
March 29, 2020
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention: The PARIS Registry
Sabato Sorrentino, Samantha Sartori, Usman Baber, et al.
Circulation. Cardiovascular Interventions
|
June 6, 2018
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)
Usman Baber, Shawn X Li, Rebecca Pinnelas, et al.
Circulation. Cardiovascular Interventions
|
April 19, 2019
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention
Michela Faggioni, Usman Baber, Samantha Sartori, et al.
The American Journal of Cardiology
|
October 2, 2018
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry)
Sabato Sorrentino, Gennaro Giustino, Usman Baber, et al.
Thrombosis and Haemostasis
|
August 1, 2019
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry
Birgit Vogel, Jaya Chandrasekhar, Usman Baber, et al.
Clinical Cardiology
|
May 21, 2015
Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design
Heerajnarain Bulluck, Georg M Fröhlich, Shah Mohdnazri, et al.
JACC. Cardiovascular Interventions
|
May 25, 2019
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry
Lauren C Joyce, Usman Baber, Bimmer E Claessen, et al.
Page
of 11